Floatz logo

Trifluridine/Tipiracil Hydrochloride Combination Agent Tas-102

Advanced Microsatellite Stable Colorectal Cancer

Gilead SciencesunclassifiedPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Advanced Microsatellite Stable Colorectal Cancer cohort.

Asset / SponsorPhaseRating
Denikitug
Gilead Sciences
Phase 2CCC
ibi305
Sun Yat-sen University
Phase 2CCC

Same molecule, other indications

Trifluridine/Tipiracil Hydrochloride Combination Agent Tas-102 is also rated in:

colorectal neoplasmDormant
B
Indicative ·
57 / 100
View asset →
metastasis from malignant tumor of colonDormant
B
Indicative ·
57 / 100
View asset →
anal carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →